These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9496896)

  • 21. Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis.
    Hall EJ
    Int J Radiat Biol; 2004 May; 80(5):327-37. PubMed ID: 15223765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint effects of radiation and smoking on lung cancer risk among Atomic bomb survivors.
    Pierce DA; Sharp GB; Mabuchi K
    Radiat Res; 2005 Jun; 163(6):694-5. PubMed ID: 16044494
    [No Abstract]   [Full Text] [Related]  

  • 23. Discussion: severe mental retardation and cancer among atomic bomb survivors exposed in utero.
    Miller RW
    Teratology; 1999 Apr; 59(4):234-5. PubMed ID: 10331525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary factors and cancer mortality among atomic-bomb survivors.
    Sauvaget C; Kasagi F; Waldren CA
    Mutat Res; 2004 Jul; 551(1-2):145-52. PubMed ID: 15225589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors by Cologne
    Walsh L; Schneider U
    Radiat Res; 2020 Feb; 193(2):195-197. PubMed ID: 31794333
    [No Abstract]   [Full Text] [Related]  

  • 27. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The present state of atomic bomb survivors, with special reference to biological late-effects of radiation].
    Kamada N
    Rinsho Byori; 2004 Mar; 52(3):217-22. PubMed ID: 15137319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ionizing radiation and cancer risk: evidence from epidemiology.
    Ron E
    Radiat Res; 1998 Nov; 150(5 Suppl):S30-41. PubMed ID: 9806607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid cancer incidence and low-dose-rate radiation exposures in the Techa River cohort: 1956 2002.
    Krestinina LY; Davis F; Ostroumova E; Epifanova S; Degteva M; Preston D; Akleyev A
    Int J Epidemiol; 2007 Oct; 36(5):1038-46. PubMed ID: 17768163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
    Kellerer AM; Rühm W; Walsh L
    Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multistage models and the A-bomb survivor data: implications for carcinogenic mechanisms?
    Moolgavkar SH
    Radiat Res; 2000 Dec; 154(6):728-9;discussion 730-1. PubMed ID: 11187016
    [No Abstract]   [Full Text] [Related]  

  • 34. Comments on "Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009" (Radiat Res 2017; 187:513-537).
    Mortazavi SMJ; Mohan D
    Radiat Res; 2017 Sep; 188(3):369-371. PubMed ID: 28632433
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
    Zhunussova T; Matsuura M; Hayakawa N
    Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reply to the Comments by Mortazavi and Doss on "Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009" (Radiat Res 2017; 187:513-537).
    Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
    Radiat Res; 2017 Sep; 188(3):370-371. PubMed ID: 28891739
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanistic models for radiation carcinogenesis and the atomic bomb survivor data.
    Pierce DA
    Radiat Res; 2003 Dec; 160(6):718-23. PubMed ID: 14640792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects.
    Suit H; Goldberg S; Niemierko A; Ancukiewicz M; Hall E; Goitein M; Wong W; Paganetti H
    Radiat Res; 2007 Jan; 167(1):12-42. PubMed ID: 17214511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of inter-individual heterogeneity into the multistage carcinogenesis model: approach to the analysis of cancer incidence data.
    Izumi S; Ohtaki M
    Biom J; 2007 Aug; 49(4):539-50. PubMed ID: 17722193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.